Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

14.30
-0.4800-3.25%
Post-market: 14.350.0500+0.35%19:30 EDT
Volume:969.16K
Turnover:14.04M
Market Cap:1.22B
PE:-8.19
High:15.00
Open:14.80
Low:14.17
Close:14.78
52wk High:25.77
52wk Low:4.52
Shares:85.31M
Float Shares:54.48M
Volume Ratio:1.07
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7450
EPS(LYR):-0.4650
ROE:-42.66%
ROA:-21.63%
PB:2.50
PE(LYR):-30.75

Loading ...

Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]